Interval estimation of odds ratio in a stratified randomized clinical trial with noncompliance

Computational Statistics and Data Analysis

Volumn 53, Issue 7, 2009, Pages 2754-2766

  Lui, Kung Jong ^a   Chang, Kuang Chao ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CURVE FITTING; FOURIER TRANSFORMS; MONTE CARLO METHODS; OPERATING ROOMS; RISK PERCEPTION;

AVERAGE LENGTHS; COVERAGE PROBABILITIES; INTERVAL ESTIMATIONS; INTERVAL ESTIMATORS; LOGARITHMIC TRANSFORMATIONS; MONTE CARLO SIMULATIONS; ODDS RATIOS; QUADRATIC EQUATIONS; RANDOMIZED CLINICAL TRIALS; RISK FACTORS; UNKNOWN PARAMETERS; WEIGHTED LEAST SQUARES;

PARAMETER ESTIMATION;

EID: 61849128850     PISSN: 01679473     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csda.2009.02.002     Document Type: Article

References (39)

1. Angrist J.D., Imbens G.W., and Rubin D.B. Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91 (1996) 444-456
2. Agresti A. Categorical Data Analysis (1990), Wiley, New York
3. Baker S.G., and Kramer B. Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis. Statistical methods in Medical Research 14 (2005) 349-367
4. Casella, G., Berger, R.L., 1990. Statistical Inference. Duxbury, Belmont, California
5. Cochran W.G. Sampling Techniques (1977), Wiley, New York
6. Cornfield J.A. Statistical problem arising from retrospective studies. In: Neyman J. (Ed). Proceedings of the Third Berkeley Symposium on Math. Statist. and Probab. vol. 4 (1956), University of California Press, Berkeley, CA 135-148
7. Fleiss J.L. Statistical Methods for Rates and Proportions. 2nd ed. (1981), Wiley, New York
8. Fleiss J.L. The Design and Analysis of Clinical Experiments (1986), Wiley, New York
9. Frangakis C.E., and Baker S.G. Compliance subsampling designs for comparative research: Estimation and optimal planning. Biometrics 57 (2001) 899-908
10. Frangakis C.E., and Rubin D.B. Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes. Biometrika 86 (1999) 365-379
11. Garrett A.D. Therapeutic equivalence: Fallacies and falsification. Statistics in Medicine 22 (2003) 741-762
12. Jacobson J.M., Spritzler J., Fox L., et al. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. Journal of Infectious Diseases 180 (1999) 61-67
13. Last J.M. A Dictionary of Epidemiology. 2nd ed. (1988), Oxford University Press, Oxford
14. Li F., and Frangakis C.E. Designs in partially controlled studies. Message from a review. Statistical Methods in Medical Research 14 (2005) 417-431
15. Little R.J., and Rubin D.B. Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytical approaches. Annual Review of Public Health 21 (2000) 121-145
16. Lui K.-J. Statistical Estimation of Epidemiological Risk (2004), Wiley, New York
17. Lui K.-J. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements. Statistics in Medicine 26 (2007) 3140-3156
18. Lui K.-J. Estimation of proportion ratio in non-compliance randomized trials with repeated measurements in binary data. Statistical Methodology 5 (2007) 129-141
19. Lui K.-J. Interval estimation of risk ratio in the simple compliance randomized trial. Contemporary Clinical Trials 28 (2007) 120-129
20. Lui, K.-J., 2008a. Notes on odds ratio estimation for a randomized clinical trial with noncompliance and missing outcomes. Department of Mathematics and Statistics, San Diego State University, CA
21. Lui K.-J. Notes on interval estimation of risk difference in stratified noncompliance randomized trials: A Monte Carlo evaluation. Computational Statistics and Data Analysis 52 (2008) 4091-4103
22. Lui K.-J., and Chang K.-C. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance. Biometrical Journal 49 (2007) 613-626
23. Lui K.-J., and Cumberland W.G. Notes on estimation of proportion ratio under a non-compliance randomized trial with missing outcomes. Computational Statistics and Data analysis 52 (2008) 4325-4345
24. Mark S.D., and Robins J.M. A method for the analysis of randomized trials with compliance information: An application to the multiple risk factor intervention trial. Controlled Clinical Trials 14 (1993) 79-97
25. Matsui S. Stratified analysis in randomized trials with noncompliance. Biometrics 61 (2005) 816-823
26. Matsuyama Y. Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: Randomized analysis approach. Statistics in Medicine 21 (2002) 675-687
27. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: Risk factor changes and mortality results. Journal of the American Medical Association 248 (1982) 1465-1477
28. O'Malley A.J., and Normand S.-L.T. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials. Biometrics 61 (2005) 325-334
29. Piantadosi S. Clinical trials: A Methodologic Perspective (1997), Wiley, New York
30. Rousson V., and Seifert B. A mixed approach for proving non-inferiority in clinical trials with binary endpoints. Biometrical Journal 50 (2008) 190-204
31. SAS Institute Inc. SAS Language, Reference Version 6. 1st ed. (1990), SAS Institute, Cary, North Carolina
32. Sato T. A method for the analysis of repeated binary outcomes in randomized clinical trials with non-compliance. Statistics in Medicine 20 (2001) 2761-2774
33. Schwartz D., and Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases 20 (1967) 637-648
34. Sheiner L., and Rubin D.B. Intention-to-treat analysis and the goals of clinical trials. Clinical Pharmacology and Therapeutics 87 (1995) 6-15
35. Sommer A., and Zeger S.L. On estimating efficacy from clinical trials. Statistics in Medicine 10 (1991) 45-52
36. Tu D. On the use of the ratio or the odds ratio of cure rates in establishing therapeutic equivalence of non-systemic drugs with binary clinical endpoints. Journal of Biopharmaceutical Statistics 8 (1998) 263-282
37. Tu D. Odds ratio. In: Chow S.C. (Ed). Encyclopedia of Biopharmaceutical Statistics (2003), Taylor & Francis Group, Dekker, New York
38. Zhao Y. Likelihood methods in randomized trials with noncompliance and subsequent nonresponse. Journal of Statistical Planning and Inference 139 (2009) 310-316
39. Zhou X.-H., and Li S.M. ITT analysis of randomized encouragement design studies with missing data. Statistics in Medicine 25 (2006) 2737-2761